Snake venom protein paralyzes cancer cells.
Finn
R
R
D017836:Agkistrodon; D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002448:Cell Adhesion / Q000187:drug effects; D002465:Cell Movement / Q000187:drug effects; D019483:Disintegrins / Q000494:pharmacology*; D015507:Drugs, Investigational / Q000494:pharmacology*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D012910:Snake Venoms / Q000494:pharmacology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D019483:Disintegrins; D015507:Drugs, Investigational; D012910:Snake Venoms; C403494:contortrostatin; C112567:etaracizumab; C422910:Cilengitide